Sergei Chavez-Abiega, Saskia de Man, Tomas Veenendaal, Julian de Swart, Jarmil Hanrath, Valeria Teodosieva, Michelle Kop, Emma Spanjaard, Virgil Woerdings, Gera Goverse
Evaluating immunotherapies requires models that capture complex tumor-immune cell interactions while enabling efficient screening.
Crown Bioscience presents a fast, high-content screening platform combining patient-derived organoid co-cultures with immune cells to assess immunotherapy responses. Using colorectal and lung cancer models, the study demonstrates comparable results between standard segmentation-based and faster fluorescence intensity-based analyses, with the potential to reduce study duration by approximately 40%.
Download the Poster to explore comparative analyses of immunotherapy responses across patient-derived organoid co-culture models and discover how streamlined high-content screening can accelerate the evaluation of emerging immunotherapies.
Your privacy is important to us.
We'll never share your information.
2026-11-05
2026-10-22
landing_page
SITC 2026